Ribon Therapeutics' Series A Round

Ribon Therapeutics raised a round of funding on December 17, 2015.

Ribon Therapeutics is pioneering the discovery and development of monoPARP (mono ADP-ribose polymerase) inhibitors to block cancer cells' fundamental ability to survive under stress.…

Articles about Ribon Therapeutics' Series A Round: